Mosaic ImmunoEngineering is a biotechnology business based in the US. Mosaic ImmunoEngineering shares (CPMV) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $0.78 – an increase of 19.38% over the previous week. Mosaic ImmunoEngineering employs 2 staff and has a market cap (total outstanding shares value) of 0.00.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.78 |
|---|---|
| 52-week range | $0.10 - $1.13 |
| 50-day moving average | $0.81 |
| 200-day moving average | $0.87 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.13 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.776 from 2025-05-02
| 1 week (2025-04-25) | 19.38% |
|---|---|
| 1 month (2025-04-04) | 19.38% |
| 3 months (2025-02-04) | -21.62% |
| 6 months (2024-11-04) | -5.25% |
| 1 year (2024-05-03) | 29.33% |
|---|---|
| 2 years (2023-05-03) | -22.40% |
| 3 years (2022-05-03) | 1.2 |
| 5 years (2020-05-01) | 1.05 |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -342.39% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | $-0.94 |
| Market Capitalization | $4.7 million |
TTM: trailing 12 months
We're not expecting Mosaic ImmunoEngineering to pay a dividend over the next 12 months.
You may also wish to consider:
Mosaic ImmunoEngineering's shares were split on a 1:500 basis on 1 December 2020 . So if you had owned 500 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Mosaic ImmunoEngineering shares – just the quantity. However, indirectly, the new 49900% higher share price could have impacted the market appetite for Mosaic ImmunoEngineering shares which in turn could have impacted Mosaic ImmunoEngineering's share price.
Over the last 12 months, Mosaic ImmunoEngineering's shares have ranged in value from as little as $0.102 up to $1.13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Mosaic ImmunoEngineering's is -1.212. This would suggest that Mosaic ImmunoEngineering's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Mosaic ImmunoEngineering has bucked the trend.
To put Mosaic ImmunoEngineering's beta into context you can compare it against those of similar companies.
Mosaic ImmunoEngineering, Inc. , a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate is MIE-101 which is based on cowpea mosaic virus which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California. .
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Some of the best stock trading apps for beginners include SoFi, Robinhood, Public, Stash, Opto and more. Compare your options here.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 7 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Fidelity is best for its extensive tools and resources, while Robinhood is a popular choice for its simple, easy-to-use platform.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .